Cargando…
Metabolomics of Synovial Fluid and Infrapatellar Fat Pad in Patients with Osteoarthritis or Rheumatoid Arthritis
Osteoarthritis (OA) and autoimmune-driven rheumatoid arthritis (RA) are inflammatory joint diseases with complex and insufficiently understood pathogeneses. Our objective was to characterize the metabolic fingerprints of synovial fluid (SF) and its adjacent infrapatellar fat pad (IFP) obtained durin...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095531/ https://www.ncbi.nlm.nih.gov/pubmed/35041143 http://dx.doi.org/10.1007/s10753-021-01604-x |
_version_ | 1784705773831454720 |
---|---|
author | Nieminen, Petteri Hämäläinen, Wilhelmiina Savinainen, Juha Lehtonen, Marko Lehtiniemi, Saara Rinta-Paavola, Juho Lehenkari, Petri Kääriäinen, Tommi Joukainen, Antti Kröger, Heikki Paakkonen, Tommi Mustonen, Anne-Mari |
author_facet | Nieminen, Petteri Hämäläinen, Wilhelmiina Savinainen, Juha Lehtonen, Marko Lehtiniemi, Saara Rinta-Paavola, Juho Lehenkari, Petri Kääriäinen, Tommi Joukainen, Antti Kröger, Heikki Paakkonen, Tommi Mustonen, Anne-Mari |
author_sort | Nieminen, Petteri |
collection | PubMed |
description | Osteoarthritis (OA) and autoimmune-driven rheumatoid arthritis (RA) are inflammatory joint diseases with complex and insufficiently understood pathogeneses. Our objective was to characterize the metabolic fingerprints of synovial fluid (SF) and its adjacent infrapatellar fat pad (IFP) obtained during the same surgical operation from OA and RA knees. Non-targeted metabolite profiling was performed for 5 non-inflammatory trauma controls, 10 primary OA (pOA) patients, and 10 seropositive RA patients with high-resolution mass spectrometry-based techniques, and metabolites were matched with known metabolite identities. Groupwise differences in metabolic features were analyzed with the univariate Welch’s t-test and the multivariate linear discriminant analysis (LDA) and principal component analysis (PCA). Significant discrimination of metabolite profiles was discovered by LDA for both SF and IFP and by PCA for SF based on diagnosis. In addition to a few drug-derived substances, there were 16 and 13 identified metabolites with significant differences between the diagnoses in SF and IFP, respectively. The pathways downregulated in RA included androgen, bile acid, amino acid, and histamine metabolism, and those upregulated included biotin metabolism in pOA and purine metabolism in RA and pOA. The RA-induced downregulation of androgen and bile acid metabolism was observed for both SF and IFP. The levels of 11 lipid metabolites, mostly glycerophospholipids and fatty acid amides, were also altered by these inflammatory conditions. The identified metabolic pathways could be utilized in the future to deepen our understanding of the pathogeneses of OA and RA and to develop not only biomarkers for their early diagnosis but also therapeutic targets. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10753-021-01604-x. |
format | Online Article Text |
id | pubmed-9095531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-90955312022-05-13 Metabolomics of Synovial Fluid and Infrapatellar Fat Pad in Patients with Osteoarthritis or Rheumatoid Arthritis Nieminen, Petteri Hämäläinen, Wilhelmiina Savinainen, Juha Lehtonen, Marko Lehtiniemi, Saara Rinta-Paavola, Juho Lehenkari, Petri Kääriäinen, Tommi Joukainen, Antti Kröger, Heikki Paakkonen, Tommi Mustonen, Anne-Mari Inflammation Original Article Osteoarthritis (OA) and autoimmune-driven rheumatoid arthritis (RA) are inflammatory joint diseases with complex and insufficiently understood pathogeneses. Our objective was to characterize the metabolic fingerprints of synovial fluid (SF) and its adjacent infrapatellar fat pad (IFP) obtained during the same surgical operation from OA and RA knees. Non-targeted metabolite profiling was performed for 5 non-inflammatory trauma controls, 10 primary OA (pOA) patients, and 10 seropositive RA patients with high-resolution mass spectrometry-based techniques, and metabolites were matched with known metabolite identities. Groupwise differences in metabolic features were analyzed with the univariate Welch’s t-test and the multivariate linear discriminant analysis (LDA) and principal component analysis (PCA). Significant discrimination of metabolite profiles was discovered by LDA for both SF and IFP and by PCA for SF based on diagnosis. In addition to a few drug-derived substances, there were 16 and 13 identified metabolites with significant differences between the diagnoses in SF and IFP, respectively. The pathways downregulated in RA included androgen, bile acid, amino acid, and histamine metabolism, and those upregulated included biotin metabolism in pOA and purine metabolism in RA and pOA. The RA-induced downregulation of androgen and bile acid metabolism was observed for both SF and IFP. The levels of 11 lipid metabolites, mostly glycerophospholipids and fatty acid amides, were also altered by these inflammatory conditions. The identified metabolic pathways could be utilized in the future to deepen our understanding of the pathogeneses of OA and RA and to develop not only biomarkers for their early diagnosis but also therapeutic targets. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10753-021-01604-x. Springer US 2022-01-18 2022 /pmc/articles/PMC9095531/ /pubmed/35041143 http://dx.doi.org/10.1007/s10753-021-01604-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Nieminen, Petteri Hämäläinen, Wilhelmiina Savinainen, Juha Lehtonen, Marko Lehtiniemi, Saara Rinta-Paavola, Juho Lehenkari, Petri Kääriäinen, Tommi Joukainen, Antti Kröger, Heikki Paakkonen, Tommi Mustonen, Anne-Mari Metabolomics of Synovial Fluid and Infrapatellar Fat Pad in Patients with Osteoarthritis or Rheumatoid Arthritis |
title | Metabolomics of Synovial Fluid and Infrapatellar Fat Pad in Patients with Osteoarthritis or Rheumatoid Arthritis |
title_full | Metabolomics of Synovial Fluid and Infrapatellar Fat Pad in Patients with Osteoarthritis or Rheumatoid Arthritis |
title_fullStr | Metabolomics of Synovial Fluid and Infrapatellar Fat Pad in Patients with Osteoarthritis or Rheumatoid Arthritis |
title_full_unstemmed | Metabolomics of Synovial Fluid and Infrapatellar Fat Pad in Patients with Osteoarthritis or Rheumatoid Arthritis |
title_short | Metabolomics of Synovial Fluid and Infrapatellar Fat Pad in Patients with Osteoarthritis or Rheumatoid Arthritis |
title_sort | metabolomics of synovial fluid and infrapatellar fat pad in patients with osteoarthritis or rheumatoid arthritis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095531/ https://www.ncbi.nlm.nih.gov/pubmed/35041143 http://dx.doi.org/10.1007/s10753-021-01604-x |
work_keys_str_mv | AT nieminenpetteri metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT hamalainenwilhelmiina metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT savinainenjuha metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT lehtonenmarko metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT lehtiniemisaara metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT rintapaavolajuho metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT lehenkaripetri metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT kaariainentommi metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT joukainenantti metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT krogerheikki metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT paakkonentommi metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis AT mustonenannemari metabolomicsofsynovialfluidandinfrapatellarfatpadinpatientswithosteoarthritisorrheumatoidarthritis |